Scientific Digital Imaging
REDUCEDespite economic slowdown, digital imaging equipment specialist SDI has issued resilient half-year results and expects to beat full year forecasts.
Interims to October from SDI, chaired by Harry Tee, CBE, revealed a creditable 7% sales rise to £3.42m, reflecting the insulation of scientific research and development budgets as well as a boost from Atik (the renamed Artemis and Perseu acquisitions from 2008), the erstwhile SDI supplier whose high-sensitivity cameras are used in certain instruments made by SDI's core Synoptics business.
Expansion of gross margins to 57.8% (2008: 54.3%) was due, among other things, to synergies arising from the inclusion of Atik, as well as increased sales of higher-value systems. However, the weaker pound against the US dollar, alongside increased investment, pegged operating profits back from £270,000 to just over £75,000.
Encouragingly, despite a slight sales decrease, Synoptics increased its margin contribution due to growing sales of higher-value systems, and sales in the US also grew, boosted by the availability of stimulus funds. Meanwhile, Atik, making good progress in the amateur astronomy market among other niche areas, scored improvements in both margin and turnover and made a good contribution to the results.
Showing pleasing resilience and still scouting for small acquisitions in a fragmented global market, SDI was forecast to deliver pre-tax profits of £120,000 for April 2010 and 0.47p of earnings, estimates the board now believes it will better.
However, on those estimates the shares, backed by Growth Company Investor at 13.5p last March and now 56% higher, trade on a rather lofty looking prospective multiple of 29 times and given the strong share price performance, some partial profit-taking might be prudent. Nevertheless, stay significantly invested for the long-term. Reduce.
- Reduce text size Decrease text size
- Increase text size Increase text size
- Print article Print
- Share this article Share
- Email article to a friend Email
Market cap: £2.43m
PE Forecast: 29
Share price: 13.5p
Subscribe today
More breaking news stories.
More extended feature articles.
And a depth of analysis you
can't find anywhere else.
Advertisement
VCT Report 2010
VCT Report 2010 uncovers the money available
for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted
company.
Order VCT Report 2010 today using this online form
Cash Shells Directory 2010
A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.
Coverage of AIM, techMARK and PLUS Markets
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
Take control of your investments
A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.
The Financial Times Guide to Personal Tax
is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.
The AIM Guide Spring 2010
The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).
A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!
Share recommendations and small-cap stock picks
Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.
Popular Recommendations
Advertisement
Latest Recommendations
Delcam 01/09/2010
Delcam, the international seller of CAD/CAM software to the engineering, aerospace and healthcare sectors among others, is a cash-generative small-cap seeing recovery in its markets.
Antisoma 01/09/2010
Bombed-out biotech play Antisoma is hoping two of its drugs will lead to good fortune after experiencing disaster with lung cancer treatment ASA404.
The Capital Pub Company 31/08/2010
London pub operator The Capital Pub Company is seeing continuing sales growth on the back of a surprisingly resilient market.
Sectors
